Quality of life of glaucoma patients under medical therapy with different prostaglandins

Ricardo Augusto Paletta Guedes,1&ndash;3 Vanessa Maria Paletta Guedes,1&ndash;3, Sirley Maria Freitas,2 Alfredo Chaoubah11Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil; 2Paletta Guedes Ophthalmological Center, Juiz de Fora, MG, Brazil; 3Santa Casa de Miseric&...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Paletta Guedes RA, Paletta Guedes VM, Freitas SM, Chaoubah A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/284016c22dcf4a4098f75a923a4da20f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:284016c22dcf4a4098f75a923a4da20f
record_format	dspace
spelling	oai:doaj.org-article:284016c22dcf4a4098f75a923a4da20f2021-12-02T04:59:50ZQuality of life of glaucoma patients under medical therapy with different prostaglandins1177-54671177-5483https://doaj.org/article/284016c22dcf4a4098f75a923a4da20f2012-10-01T00:00:00Zhttp://www.dovepress.com/quality-of-life-of-glaucoma-patients-under-medical-therapy-with-differ-a11388https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Ricardo Augusto Paletta Guedes,1&ndash;3 Vanessa Maria Paletta Guedes,1&ndash;3, Sirley Maria Freitas,2 Alfredo Chaoubah11Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil; 2Paletta Guedes Ophthalmological Center, Juiz de Fora, MG, Brazil; 3Santa Casa de Miseric&oacute;rdia Hospital, Juiz de Fora, Minas Gerais, BrazilPurpose: To assess the quality of life of glaucoma patients under medical therapy with different prostaglandin analogs.Methods: A cross-sectional study of consecutive glaucoma patients was designed. We assessed the patients&#39; quality of life through the Brazilian 25-question version of the National Eye Institute Visual Functioning Questionnaire, comprising 12 subscales (general health, general vision, ocular pain, near vision, distance vision, social function, mental health, role limitations, dependency, driving, color vision, and peripheral vision) and a total composite score. Clinical features, including current medical treatment, were obtained from each patient&#39;s medical record. Three groups of patients were identified according to the prostaglandin in use: bimatoprost, latanoprost, or travoprost. The main outcome measures were: mean score in each subscale and mean total composite score.Results: The mean total composite score for the whole group was 70.60. The bimatoprost, latanoprost, and travoprost groups had the following mean composite scores, respectively: 56.56, 77.36, and 71.08 (P = 0.001, analysis of variance [ANOVA]). Latanoprost and travoprost results were similar, and both were superior to bimatoprost. Most subscales had similar results. The subscale with the lowest score for all groups was general health. Groups were homogenous and comparable.Conclusion: There is a difference in the quality of life between glaucoma patients using prostaglandin analogs. It seems that bimatoprost users have lower QoL when compared to latanoprost and travoprost users.Keywords: glaucoma, medical treatment, prostaglandin analogs, quality of lifePaletta Guedes RAPaletta Guedes VMFreitas SMChaoubah ADove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2012, Iss default, Pp 1749-1753 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Paletta Guedes RA Paletta Guedes VM Freitas SM Chaoubah A Quality of life of glaucoma patients under medical therapy with different prostaglandins
description	Ricardo Augusto Paletta Guedes,1&ndash;3 Vanessa Maria Paletta Guedes,1&ndash;3, Sirley Maria Freitas,2 Alfredo Chaoubah11Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil; 2Paletta Guedes Ophthalmological Center, Juiz de Fora, MG, Brazil; 3Santa Casa de Miseric&oacute;rdia Hospital, Juiz de Fora, Minas Gerais, BrazilPurpose: To assess the quality of life of glaucoma patients under medical therapy with different prostaglandin analogs.Methods: A cross-sectional study of consecutive glaucoma patients was designed. We assessed the patients&#39; quality of life through the Brazilian 25-question version of the National Eye Institute Visual Functioning Questionnaire, comprising 12 subscales (general health, general vision, ocular pain, near vision, distance vision, social function, mental health, role limitations, dependency, driving, color vision, and peripheral vision) and a total composite score. Clinical features, including current medical treatment, were obtained from each patient&#39;s medical record. Three groups of patients were identified according to the prostaglandin in use: bimatoprost, latanoprost, or travoprost. The main outcome measures were: mean score in each subscale and mean total composite score.Results: The mean total composite score for the whole group was 70.60. The bimatoprost, latanoprost, and travoprost groups had the following mean composite scores, respectively: 56.56, 77.36, and 71.08 (P = 0.001, analysis of variance [ANOVA]). Latanoprost and travoprost results were similar, and both were superior to bimatoprost. Most subscales had similar results. The subscale with the lowest score for all groups was general health. Groups were homogenous and comparable.Conclusion: There is a difference in the quality of life between glaucoma patients using prostaglandin analogs. It seems that bimatoprost users have lower QoL when compared to latanoprost and travoprost users.Keywords: glaucoma, medical treatment, prostaglandin analogs, quality of life
format	article
author	Paletta Guedes RA Paletta Guedes VM Freitas SM Chaoubah A
author_facet	Paletta Guedes RA Paletta Guedes VM Freitas SM Chaoubah A
author_sort	Paletta Guedes RA
title	Quality of life of glaucoma patients under medical therapy with different prostaglandins
title_short	Quality of life of glaucoma patients under medical therapy with different prostaglandins
title_full	Quality of life of glaucoma patients under medical therapy with different prostaglandins
title_fullStr	Quality of life of glaucoma patients under medical therapy with different prostaglandins
title_full_unstemmed	Quality of life of glaucoma patients under medical therapy with different prostaglandins
title_sort	quality of life of glaucoma patients under medical therapy with different prostaglandins
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/284016c22dcf4a4098f75a923a4da20f
work_keys_str_mv	AT palettaguedesra qualityoflifeofglaucomapatientsundermedicaltherapywithdifferentprostaglandins AT palettaguedesvm qualityoflifeofglaucomapatientsundermedicaltherapywithdifferentprostaglandins AT freitassm qualityoflifeofglaucomapatientsundermedicaltherapywithdifferentprostaglandins AT chaoubaha qualityoflifeofglaucomapatientsundermedicaltherapywithdifferentprostaglandins
_version_	1718400879082602496

Quality of life of glaucoma patients under medical therapy with different prostaglandins

Ejemplares similares